{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:03:34Z","timestamp":1788782614872,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.ejphar.2020.173171","type":"journal-article","created":{"date-parts":[[2020,5,10]],"date-time":"2020-05-10T23:54:26Z","timestamp":1589154866000},"page":"173171","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse"],"prefix":"10.1016","volume":"880","author":[{"suffix":"III","given":"William A.","family":"Eckert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.M.","family":"Wiener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Cai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Ameriks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-Ping","family":"Fung-Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin L.","family":"Thurmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Grice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra R.","family":"Chaplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siquan","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2020.173171_bib1","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1016\/j.bmcl.2009.09.014","article-title":"Pyrazole-based cathepsin S inhibitors with arylalkynes as P1 binding elements","volume":"19","author":"Ameriks","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib2","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.pain.2006.11.017","article-title":"Role of the cysteine protease cathepsin S in neuropathic hyperalgesia","volume":"130","author":"Barclay","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173171_bib3","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/eji.200737485","article-title":"CNS-infiltrating CD4+ T lymphocytes contribute to murine spinal nerve transection-induced neuropathic pain","volume":"38","author":"Cao","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.ejphar.2020.173171_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0165-0270(94)90144-9","article-title":"Quantitative assessment of tactile allodynia in the rat paw","volume":"53","author":"Chaplan","year":"1994","journal-title":"J. Neurosci. Methods"},{"key":"10.1016\/j.ejphar.2020.173171_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0952-7915(98)80038-1","article-title":"Endosomal proteolysis and MHC class II function","volume":"10","author":"Chapman","year":"1998","journal-title":"Curr. Opin. Immunol."},{"key":"10.1016\/j.ejphar.2020.173171_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.expneurol.2011.09.012","article-title":"Microglial signalling mechanisms: cathepsin S and fractalkine","volume":"234","author":"Clark","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2020.173171_bib7","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/glia.21042","article-title":"Cathepsin S release from primary cultured microglia is regulated by the P2X7 receptor","volume":"58","author":"Clark","year":"2010","journal-title":"Glia"},{"key":"10.1016\/j.ejphar.2020.173171_bib8","doi-asserted-by":"crossref","first-page":"10655","DOI":"10.1073\/pnas.0610811104","article-title":"Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain","volume":"104","author":"Clark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejphar.2020.173171_bib9","doi-asserted-by":"crossref","first-page":"6945","DOI":"10.1523\/JNEUROSCI.0828-09.2009","article-title":"The liberation of fractalkine in the dorsal horn requires microglial cathepsin S","volume":"29","author":"Clark","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173171_bib10","doi-asserted-by":"crossref","first-page":"14415","DOI":"10.1523\/JNEUROSCI.4569-09.2009","article-title":"T-cell infiltration and signaling in the adult dorsal spinal cord is a major contributor to neuropathic pain-like hypersensitivity","volume":"29","author":"Costigan","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2020.173171_bib11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0304-3959(00)00276-1","article-title":"Spared nerve injury: an animal model of persistent peripheral neuropathic pain","volume":"87","author":"Decosterd","year":"2000","journal-title":"Pain"},{"key":"10.1016\/j.ejphar.2020.173171_bib12","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1021\/jo902650b","article-title":"Practical synthesis of a Cathepsin S inhibitor: route identification, purification strategies, and serendipitous discovery of a crystalline salt form","volume":"75","author":"Deng","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejphar.2020.173171_bib13","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev.pa.20.040180.002301","article-title":"Efficient analysis of experimental observations","volume":"20","author":"Dixon","year":"1980","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.ejphar.2020.173171_bib14","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/j.bbi.2011.04.003","article-title":"Peripheral immune contributions to the maintenance of central glial activation underlying neuropathic pain","volume":"25","author":"Grace","year":"2011","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.ejphar.2020.173171_bib15","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1016\/j.bmcl.2006.01.038","article-title":"The SAR of 4-substituted (6,6-bicyclic) piperidine cathepsin S inhibitors","volume":"16","author":"Grice","year":"2006","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1124\/jpet.116.232926","article-title":"Selective cathepsin S inhibition with MIV-247 attenuates mechanical allodynia and enhances the antiallodynic effects of gabapentin and pregabalin in a mouse model of neuropathic pain","volume":"358","author":"Hewitt","year":"2016","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejphar.2020.173171_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0306-4522(02)00065-9","article-title":"Macrophage and lymphocyte invasion of dorsal root ganglia after peripheral nerve lesions in the rat","volume":"112","author":"Hu","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173171_bib18","doi-asserted-by":"crossref","first-page":"5502","DOI":"10.1021\/jm800839j","article-title":"Discovery of orally bioavailable cathepsin S inhibitors for the reversal of neuropathic pain","volume":"51","author":"Irie","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173171_bib19","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1213\/00000539-199802000-00025","article-title":"The effect of intrathecal gabapentin and 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat","volume":"86","author":"Jun","year":"1998","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.ejphar.2020.173171_bib20","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1016\/j.bmcl.2010.01.108","article-title":"Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors: part 1","volume":"20","author":"Lee-Dutra","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1600-065X.1999.tb01361.x","article-title":"The role of lysosomal proteinases in MHC class II-mediated antigen processing and presentation","volume":"172","author":"Nakagawa","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2020.173171_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(98)00648-X","article-title":"A novel model of primary and secondary hyperalgesia after mild thermal injury in the rat","volume":"254","author":"Nozaki-Taguchi","year":"1998","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2020.173171_bib23","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1016\/j.neuroscience.2008.04.047","article-title":"Fatty acid amide hydrolase inhibition enhances the anti-allodynic actions of endocannabinoids in a model of acute pain adapted for the mouse","volume":"154","author":"Palmer","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejphar.2020.173171_bib24","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1067\/S1526-5900(03)00781-8","article-title":"Spared nerve injury model of neuropathic pain in the mouse: a behavioral and anatomic analysis","volume":"4","author":"Shields","year":"2003","journal-title":"J. Pain"},{"key":"10.1016\/j.ejphar.2020.173171_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1600-065X.1999.tb01360.x","article-title":"Proteases involved in MHC class II antigen presentation","volume":"172","author":"Villadangos","year":"1999","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.ejphar.2020.173171_bib26","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1074-7613(00)80176-4","article-title":"Proteolysis in MHC class II antigen presentation: who's in charge?","volume":"12","author":"Villadangos","year":"2000","journal-title":"Immunity"},{"key":"10.1016\/j.ejphar.2020.173171_bib27","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.bmcl.2010.01.103","article-title":"Thioether acetamides as P3 binding elements for tetrahydropyrido-pyrazole cathepsin S inhibitors","volume":"20","author":"Wiener","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2174\/156802610791113432","article-title":"Recent advances in the design of cathepsin S inhibitors","volume":"10","author":"Wiener","year":"2010","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejphar.2020.173171_bib29","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1016\/j.bmcl.2010.01.104","article-title":"Discovery and SAR of novel pyrazole-based thioethers as cathepsin S inhibitors. Part 2: modification of P3, P4, and P5 regions","volume":"20","author":"Wiener","year":"2010","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib30","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.bmcl.2012.12.014","article-title":"Pyrazole-based arylalkyne cathepsin S inhibitors. Part III: modification of P4 region","volume":"23","author":"Wiener","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejphar.2020.173171_bib31","doi-asserted-by":"crossref","first-page":"3013","DOI":"10.1523\/JNEUROSCI.3681-13.2014","article-title":"Peripheral role of cathepsin S in Th1 cell-dependent transition of nerve injury-induced acute pain to a chronic pain state","volume":"34","author":"Zhang","year":"2014","journal-title":"J. Neurosci."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299920302636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:39:17Z","timestamp":1757975957000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299920302636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":31,"alternative-id":["S0014299920302636"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173171","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective inhibition of peripheral cathepsin S reverses tactile allodynia following peripheral nerve injury in mouse","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2020.173171","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"173171"}}